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W e also have a fourth possibility, namely 
that the changes in metabolism may be taking 
place only in the brain although the same 
metabolic process is to be found also in other 
tissues. If this situation exists it may be im­
possible to infer changes in cerebral tissue from 
changes in metabolites in blood and urine.
Studies of cerebral metabolism in depressive 
illness are necessary in each of the above situ­
ations. In 1, 2 and 3 above they are necessary 
to justify the assumptions relating general and 
cerebral metabolism, whilst in case 4 the 
information is not obtainable by any other 
technique.
T E C H N I Q U E S  F O R  T H E  S T U D Y  O F  C E R E B R A L  
M E T A B O L I S M
Advances in the direct biochemical study of 
diseases affecting the brain have been made 
using two main types of technique :
1. The analysis of brain tissue obtained at 
post mortem or as biopsy material during 
neurosurgical operation. This technique 
has been particularly valuable when the 
biochemical abnormality involves structural 
components of neural tissue, e.g. in the 
cerebral lipoidoses.
2. The establishment of animal models of the 
disease allowing careful control of vari- 
ables and biochemical studies at varying 
stages of the disease. This approach has 
provided valuable evidence, e.g. in the 
vitamin deficiency states.
( M ed ic a l  R es ea rch  C ounc il)
The suggestion that depressive illness may be 
associated with biochemical or metabolic dis­
turbance is not new but added impetus has 
been given to this approach in recent years by 
the success of physical methods of treatment, 
e.g. electroconvulsive therapy and the antide­
pressant drugs. Studies of electrolyte distribu­
tion, adrenal steroid hormones and the meta­
bolism of the biogenic amines have occupied 
most attention, and excellent reviews of 
changes reported in depression are available by 
Durell and Schildkraut, and Coppen (1967).
Biochcmical studies in depression. The 
majority of the published studies have been 
carried out in relation to “ whole body”  meta- 
bolism, using blood and urinary estimation of 
metabolites. W hilst we would agree that 
depressive illness is a disease of the whole per- 
son we would argue that the most important 
and significant disturbances involve the higher 
nervous functions. Thus studies of general 
body metabolism will be of relevance only if 
certain special conditions are fulfilled :
1. If it is known that the whole body 
changes in metabolism are paralleled by 
cerebral changes; 
or 2. If the metabolites measured in blood and 
urine have brain as their only source and 
and are not produced in any other tissue; 
or 3. If changes in blood chemistry are found 
the effects of which arc known from 
previous studies, e.g. hypoxia or hypo- 
glycaemia.
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W hilst tests of the biochemical functions of 
many organs are in regular clinical use, e.g. 
liver function tests, renal function tests, the 
design of studies of biochemical functions of 
the brain in living man are limited by its 
inaccessibility. Logically it would seem that 
there are only two practical approaches to the 
study of the biochemical functioning of the 
living brain, the estimation of arteriovenous 
differences of metabolites and the estimation 
of metabolites released from brain into the 
cerebrospinal fluid.
In depressive illness the biochemical approach 
to the brain is further limited for our patients 
do not die from the disease process, though 
they may die because of it, e.g. by suicide. In 
addition we are unable to devise an acceptable 
animal model of the disease. W e must look, 
therefore, to studies in the living patient to 
provide us with our information. M y colleagues 
and I in the U nit for Research in Brain M eta- 
bolism decided to investigate the possibility 
of using the release of a cerebral metabolite 
into the cerebrospinal fluid for the purpose 
of examining the possibility of a disturbance 
of amine metabolism in depressive illness.
T h e A m ine Hypothesis —  a specific hypo- 
thesis relating depressive illness to changes in 
the cerebral metabolism of the biogenic amines.
A  number of biogenic amines are found in 
brain tissue including histamine, 5-hydroxy- 
tryptamine, noradrenaline and dopamine. 
W hilst there is a rough parallel between the 
distribution of the amines in brain in that they 
tend to be concentrated in central structures 
and basal ganglia, there are also differences in 
the distribution of the individual amines which 
suggest specific relationships to certain physio- 
logical systems. Studies of the distribution of 
the amines have been facilitated by the applic- 
ation of the technique of fluorescence micro- 
scopy (Fuxe et al (1965) ) by which the amine- 
containing cells and fibre tracts can be visual- 
ized in histological preparations. The sug- 
gestion that the amines function as transmitter 
substances at central synapses has received 
support from the. fluorescence microscopy 
studies. Such studies have suggested a possible 
role of dopamine as a transmitter in the extra- 
pyramidal system and changes in dopamine 
levels in parts of this system arc reported in 
Parkinsonism.
5-Hydroxytryptamine is concentrated in parts 
of the lim bic system, e.g. the hypothalamus, 
amygdala and hippocampus, whilst noradrena
line is concentrated in hypothalamus and mid 
brain, possibly in relationship to systems in­
volved in central autonomic control.
Th e evidence for a disturbance of amine 
metabolism is presented by D urell and Schild- 
kraut (1964) and C oppen (1967), and is based 
on the known actions of drugs which either 
precipitate' or are used to treat depressive ill- 
ness. In general terms drugs which can precip- 
itate depression in susceptible individuals, e.g. 
reserpine, reduce the concentrations of 5-H .T. 
and noradrenaline, whilst the antidepressant 
drugs either increase brain amine levels (mono- 
amine oxidase inhibitors) or potentiate the 
effects of the released amines (tricyclic group 
of drugs). Thus a general hypothesis can be 
advanced to relate changes in amine meta­
bolism to depressive illness.
W O R K I N G  H Y P O T H E S I S
“ That depression will occur whenever the 
levels of biogenic amines arc reduced at reactive 
sites in Brain” .
This hypothesis makes no attem pt to dis­
tinguish between the relative importance of 
changes in noradrenaline, dopamine and 5-H .T, 
metabolism. Our first attempts to investigate 
this problem were, however, limited to 
investigation of 5-H .T. Later studies and also 
studies by Dencker et al (1966) have included 
studies of dopamine metabolism. T o  date 
studies of noradrenaline have been handicapped 
by the failure to detect its metabolites in cere- 
brospinal fluid.
T h e metabolism of 5-hydroxytryptamine in 
brain is illustrated diagramatieally in Fig 1.
AMINO ACID PRECURSOR TRYPTOPHAN
BLO O D  BR A IN   
B A R R IE R  
H Y D R O X Y L A S E
5 HTP
< — D E C A R B O X Y L A S E ------>  
*
AMINE 5HT
— M ONOAMINE O X I D A S E * ^  
ACID METABOLITE 5HIAA
BLOOD < ----------------------- C.S.F
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levels of amine metabolites and brain and 
to investigate the mechanisms for the 
removal of the acids from C S F .
H U M A N  S T U D I E S
T h e results of such a study are shown in 
Table 1. (Ashcroft et al (1966)). T h ey appear to 
confirm the hypothesis of a disturbance of 
cerebral 5-H .T. metabolism in depressive ill- 
ness, the low levels of s-H IA A  in the lum bar 
cerebrospinal fluid of the depressed patients 
being consistent with a defect in the release or 
synthesis of the amine. Further studies revealed' 
a correlation between the severity of the de-
CO N C EN T R AT IO N S O F  5- H Y D RO XY IN D O LE  C O M PO U N D S IN  C ER EB RO SP IN A L  FLU ID
Type of Patient No.
Site and M ethod of 
C.S.F. Sampling
Concentration of 
5-hydroxyindoles + 
(ng. per m l. + S.D.)
Neurosurgical .......................... 6 Ventricular drainage 88.1 (+ 22.6)
Neurological (organic disease
of the central nervous
system):
Neurological U n it ............ 28 Lumbar air-
encephalography
33.3 (±11.2)
Neurological U nit ............ 7 Lumbar puncture 17.4 (± 5.3)]
Psychiatric U n it ................... 8 Lumbar puncture 20.0 (+ 4.7) ( 19.1 (± 4.4)
A lcoholic .................................... 6 Lumbar puncture 19.8 (± 2.9)
Depressed:
On im ipramine ................. 8 Lumbar puncture
1 0 . 3  ( ±3.8)
On no specific antidepres­
sant ...................................
24 Lumbar puncture
Hypomanic .............................. 4 Lumbar puncture 18.7 (± 5.4)
Schizophrenic:
Acute ................................... 7 Lumbar puncture 10.9 (± 2.3)
Chronic .......................... 7 Lumbar puncture 16.4 (± 2.9)
T h e amino acid tryptophan is actively trans- 
ported from blood into brain tissue where it is 
hydroxylated to 5-hydroxytryptophan. T h e 
5-hydvoxytrytophan is then decarboxylated to 
the amine 5-hydroxytryptamine which is 
metabolised to 5-hydroxyincloI - 3ylacetie acid 
(5-H IA A ) after release. T h e  5-H IA A  is then 
cleared into blood directly or via the cerebro­
spinal fluid. Since 5-H IA A  does not pass in the 
reverse direction from blood to cerebrospinal 
fluid we argued that the levels of 5-IIIA A  in 
the fluid would reflect the levels of the acid in 
the brain and that this in turn would reflect 
the turnover of parent amine 5-hydroxytrypt- 
amine.
* Concentration of 5-hydroxyindoles expressed as 5-H.I.A.A. 
(Reprinted from THE LANCET, November 12, 1966, pp. 1049-1052).
T h e identification of the acid in human 
cerebrospinal fluid gave preliminary results 
indicating a difference between the levels in 
patients with depressive illness and a group of 
nondepressed patients with neurological disease. 
Ashcroft and Sharman (1960) suggested that 
this approach might be a fruitful one. Sub­
sequent studies have been directed to further 
investigation of these problems and have been 
of two types:
1. Studies of C S F  levels in man;
2. Anim al studies designed to examine the 
relationship between cerebrospinal fluid
pression and 5-H IAA levels and also a return 
towards normal of the levels with remission 
from the illness irrespective of the type of 
treatm ent (E C T  or imipramine).
Confirm ation of these results was provided 
in a study by Dencker et al (1966) who also 
extended the findings by measuring homo- 
vanillic acid, the metabolite of dopamine. 
W h ilst they found the levels-of 5-H IA A  to be 
reduced the levels of H V A  were within normal 
limits in depressed patients.
Closer inspection of the results in Table ] 
reveals an alternative explanation of the low
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levels of 5-HIAA in depression which must be 
considered before we can accept them as 
indicating an alteration of cerebral metabolism. 
In nondepressed subjects there is a gradient in 
levels from ventricular fluid to lumbar CSF. 
Fluid obtained at air encephalography which 
may be considered as a mixture of ventricular 
fluid displaced by injected air with C S F  from 
other levels has a concentration of 5-IIIAA 
part way between that of lumbar and ventri- 
cular fluid. These results suggest that the 5- 
H IAA is added to the ventricular fluid and 
removed as the fluid passes down the cerebro- 
spinal axis. Thus low levels in lumbar cerebro- 
spinal fluid could represent either less addition 
at ventricular levels or a greater degree of 
removal as the C S F  passes down to the lumbar 
region.
A N I M A L  E X P E R I M E N T S
The relationship between the concentration 
of 5 H IA A  in C.S.F. obtained from different 
levels of the cerebrospinal axis and the meta­
bolism of the parent amine in brain was thus 
revealed as a complex one and it seemed un­
likely that the problems could be resolved in 
clinical studies. Animal studies were thus 
utilised and have provided the vital links in 
the chain which may now allow us to move 
forward again with studies in man.
1. Relationship between Cerebrospinal fluid
and brain levels.
Studies were made using a technique allow­
ing the sampling of C S F  from the lateral 
ventricles and cisterna of the dog and the fol­
lowing results were obtained.
(1) The levels of homovanillic acid in the 
lateral ventricular fluid reflects the levels 
of the acid in the underlying brain tissue, 
i.e., the caudate nucleus. Levels of 5-HIAA 
are higher than might be expected if 
caudate nucleus were the only source of 
the acid and it suggested that structures in 
the inferior horn of the lateral ventricle, 
viz. the amygdala and hippocampus, may 
contribute to the levels. (Guldberg et al 
(1966)).
(2) The levels of 5-hydroxyindol - 3 ylacetic 
acid in the cisternal fluid reflect concentr- 
ations in mid-brain and hind-brain. 
(Eccleston et al (1967)).
2. Active transport of acid metabolites from
brain and C S F  to blood.
Experimental studies by Pappenheimer et al 
(1961) and Davson et al (1962) have demon- 
strated the presence of a transport mechanism 
capable of actively transporting certain organic 
acids, e.g., diodrast and para amino hippuric 
acid from cerebrospinal fluid into blood. This 
mechanism appears similar to the renal tubular 
mechanism which transports organic acid, 
and the suggestion is made that it is a property 
of the choroid plexus. W e reasoned that the 
gradient in levels of 5-H IAA noted in our 
patients between ventricular and lumbar fluid 
could have resulted from the action of such a 
transport mechanism and animal experiments 
were designed to test this hypothesis.
(a) A  comparison of ventricular and cisternal 
C S F  levels of 5-H IAA and HV A  in the dog 
revealed a similar gradient to that observed in 
man.
Pretreatment of the animals with probenieid, 
a drug which blocks the renal transport mech- 
anism for organic acids, was shown to reduce 
significantly the gradient levels of 5-IIIAA and 
H V A  between ventricles and cisterna with a 
marked relative rise in cisternal acid levels. 
Guldberg et al (1967). Such a result is con- 
sistent with the presence of an active transport 
mechanism for the organic acids situated in the 
C S F  pathway.
(b) A  technique was developed for the per­
fusion of the cerebral ventricles in the conscious 
dog similar to that used in the goat by Pappen- 
heimer (1961). Such a method (Ashcroft et 
al (1967)) was used to study the clearance of 
5-H IAA and HV A  and inulin from the C SF, 
the results confirming the presence of an active 
transport mechanism for the acids and localis- 
ing it in the fourth ventricle. Neff et al (1964) 
have provided evidence for a similar transport 
mechanism for 5-HIAA from brain tissue to 
blood.
C O N C L U S I O N S
The studies described in brief above repre- 
sent an attempt to develop a technique for the 
study of the cerebral metabolism of 5-hydroxy- 
tryptamine in patients with depressive illness. 
The progressive evaluation of the technique 
has required the use of animal experimental 
procedures to examine the relationship between 
C S F  and brain in addition to studies in man.
Our simple model (Fig. 1) must be amended 
in light of these studies to show a variation in 
5-HIAA levels with the site of C S F  sampling
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and to include the concept of active transport 
rather than the passive diffusion of acid meta- 
bolites from brain and C S F  into blood.
T h e  results of the C S F  studies in depressed 
patients showed lowered levels of 5-H IAA  but 
normal H V A  levels in lum bar fluid. Such a 
selective lowering of 5-H IAA  levels argues 
against an increased rate of transport of the 
acid from  C S F  as disturbance of such a m ech­
anism would be expected to lower concentra­
tions of both H V A  and 5-H IA A . W e  must 
conclude, therefore, that the findings appear 
to indicate a diminished release or synthesis 
of the amine 5-hydroxytryptamine in the brain 
of the depressed patient and would suggest that 
the most likely defect is in the hydroxylation 
of tryptophan.
T h e  results, however, give us only a glimpse 
of the problem and the investigations have left 
us with more questions to answer than when 
we started, e.g. are the symptoms of depressive 
illness causally related to the change in amine
metabolism? D o different depressive clinical 
syndromes have different associated bio­
chemical findings? Can the biochemical find­
ings be shown to have any predictive value in 
terms of treatment and prognosis?
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Duel purpose
“ Hence, notwithstanding a most keen and illiberal persecution, which the new doctrine sus­
tained from Cullen and his adherents, the disciples of Brown, from their numbers, shortly became 
so form idable to their adversaries that the latter, upon all occasions, and in all public societies, 
were perpetually annoyed and molested by them. T h e  palaestra, where their contests were 
maintained with the greatest violence, was the Royal M edical Society. H ere the partisans of both 
doctrines used to assemble weekly; and the debates on each side were conducted with such 
vehemence and intemperance, that they very com m only terminated in one member calling out 
another to the field. Such encounters had so frequently disgraced the Society, that, in order to 
prevent the growing evil, it became necessary to pass a law, by which it was enacted, that any 
member, who challenged another, in consequence of what had been said in the public debates, 
should be expelled the Society.”
— from a Biographical Account of Dr. John Brow n by W illiam  Cullen Brown (1804): John 
Brown was President of the R .M .S . three times, and during his third term of office published the 
“ Elem enta M edicinae” , expounding his system of medicine which raised a great deal of contro­
versy in Edinburgh, but had more success on the Continent.
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